Abnormal Clotting in Cancer: An Overview of Pathophysiology and Etiology

De Cicco, 2004, The prothrombotic state in cancer, Crit Rev Oncol Hematol, 50, 187, 10.1016/j.critrevonc.2003.10.003 Gao, 2004, Venous thromboembolism and malignancy, Expert Rev Anticancer Ther, 4, 303, 10.1586/14737140.4.2.303 Falanga, 2004, Venous thromboembolism in oncology, Exp Oncol, 26, 11 Lee, 2005, Management of thrombosis in cancer, Br J Haematol, 128, 291, 10.1111/j.1365-2141.2004.05292.x Kakkar, 2004, Thrombosis and cancer, Hematol J, 3, 20, 10.1038/sj.thj.6200416 Deitcher, 2003, Cancer-related deep venous thrombosis, Semin Thromb Hemost, 3, 247 Kwaan, 2003, Pathogenesis of increased risk of thrombosis in cancer, Semin Thromb Hemost, 29, 283, 10.1055/s-2003-40966 Goad, 1996, Coagulation disorders in cancer, Hematol Compl Cancer, 10, 457 Falanga, 2003, Clotting mechanisms and cancer, Clin Adv Hematol Oncol, 1, 669 Piccioli, 1996, Cancer and venous thromboembolism, Am Heart J, 13, 850, 10.1016/S0002-8703(96)90321-X Deitcher, 2003, Hypercoagulable state testing and malignancy screening following venous thromboembolic events, Vascular Med, 8, 33, 10.1191/1358863x03vm461ra Fernandez, 2004, Tissue factor and fibrin in tumor angiogenesis, Semin Thromb Hemost, 30, 31, 10.1055/s-2004-822969 Gouin-Thibault, 2001, The thrombophilic state in cancer patients, Acta Haematologica, 106, 33, 10.1159/000046587 Prandoni, 2005, Cancer and venous thromboembolism, Lancet Oncol, 6, 401, 10.1016/S1470-2045(05)70207-2 Van Gerpen, 2004, Thromboembolic disorders in cancer, Clin J Oncol Nurs, 8, 289, 10.1188/04.CJON.289-299 Levi, 2003, Therapeutic options in patients with DIC and cancer, Pathophysiology of Haemost Thromb, 33, 46, 10.1159/000073291 Eichiger, 2000, Cancer-related coagulopathic complications Barger, 2000, Evaluation of the hypercoagulable state. Whom to screen, how to test and treat, Postgrad Med, 108, 59, 10.3810/pgm.2000.09.15.1236 Bauer KA: When to do a “hypercoagulable workup.” Hematologist Mini-Review, Am Soc Hematol 2005. Available at: http://www.hematology.org/publications/hematologist/jfm04/review.cfm (accessed Nov 7, 2005). Verso, 2003, Venous thromboembolism associated with long-term use of central venous catheters in cancer patients, J Clin Oncol, 21, 3665, 10.1200/JCO.2003.08.008 Bern, 1990, Very low doses of warfarin can prevent thrombosis in central venous catheters, Ann Intern Med, 112, 423, 10.7326/0003-4819-76-3-112-6-423 Carr, 2000, Physician compliance with warfarin prophylaxis for central venous catheters in patients with solid tumors, J Clin Oncol, 18, 3665, 10.1200/JCO.2000.18.21.3665 Kuter, 2004, Thrombotic complications of central venous catheters in cancer patients, Oncologist, 9, 207, 10.1634/theoncologist.9-2-207 Verso, 2005, Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter, J Clin Oncol, 23, 4057, 10.1200/JCO.2005.06.084 Goodnough, 1984, Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen, Cancer, 54, 1264, 10.1002/1097-0142(19841001)54:7<1264::AID-CNCR2820540706>3.0.CO;2-R Rogers JS, 1988, Chemotherapy for breast cancer decreases plasma protein C and protein S, J Clin Oncol, 6, 276, 10.1200/JCO.1988.6.2.276 Deitcher, 2004, The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma, Cancer, 101, 439, 10.1002/cncr.20347 Mehta, 2003, Thalidomide as anti-inflammatory therapy for multiple myeloma, Leukemia, 17, 2237, 10.1038/sj.leu.2403118 Dimopoulos, 2004, Adverse effects of thalidomide administration in patients with neoplastic diseases, Am J Med, 117, 508, 10.1016/j.amjmed.2004.03.040 Kuzel, 1990, Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatin, Cancer, 65, 885, 10.1002/1097-0142(19900215)65:4<885::AID-CNCR2820650410>3.0.CO;2-H Shah, 2005, Thromboembolic events in gastric cancer, J Clin Oncol, 23, 2574, 10.1200/JCO.2005.81.908 Bokemeyer, 2004, EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer, Eur J Cancer, 40, 2201, 10.1016/j.ejca.2004.07.015 Lee, 2003, Low molecular weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer, N Engl J Med, 349, 146, 10.1056/NEJMoa025313 Zacharski, 2005, Warfarin versus low-molecular-weight heparin therapy in cancer patients, Oncol, 10, 72, 10.1634/theoncologist.10-1-72 Altinbas, 2004, A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer, J Thromb Haemost, 2, 1266, 10.1111/j.1538-7836.2004.00871.x Klerk, 2005, The effect of low molecular weight heparin on survival in patients with advanced malignancy, J Clin Oncol, 23, 2130, 10.1200/JCO.2005.03.134